Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-01-27
DOI
10.1038/srep17714
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of PAI-1 and Fibrinogen With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT)
- (2013) N. Azad et al. DIABETES CARE
- Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis
- (2013) G.-C. Chen et al. Obesity Reviews
- Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation
- (2012) J. Huang et al. BLOOD
- Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study
- (2012) Jenny Hernestål-Boman et al. Cardiovascular Diabetology
- The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS)
- (2012) C. C. Lee et al. DIABETOLOGIA
- Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
- (2011) Zaid Al-Hamodi et al. Cardiovascular Diabetology
- Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus
- (2011) Marie-Christine Alessi et al. THROMBOSIS AND HAEMOSTASIS
- Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells
- (2010) Prachi Singh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Hemostatic System in Patients With Type 2 Diabetes With and Without Cardiovascular Disease
- (2010) Chantal J. N. Verkleij et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Circulating vascular endothelial growth factor in the normo- and/or microalbuminuric patients with type 2 diabetes mellitus
- (2009) Peter Kubisz et al. ACTA DIABETOLOGICA
- Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2
- (2009) Thomas W Jax et al. Cardiovascular Diabetology
- PAI-1 and D-Dimer in Type 2 Diabetic Women With Asymptomatic Macrovascular Disease Assessed by Carotid Doppler
- (2009) Anna Letícia Soares et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Human IL6 enhances leptin action in mice
- (2009) M. Sadagurski et al. DIABETOLOGIA
- Adiponectin Levels and Risk of Type 2 Diabetes
- (2009) Shanshan Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasminogen Activator Inhibitor-1 Activity in Type 2 Diabetes
- (2008) Laima Brazionis et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Tissue Plasminogen Activator, von Willebrand Factor, and Risk of Type 2 Diabetes in Older Men
- (2008) S. G. Wannamethee et al. DIABETES CARE
- The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes
- (2008) Duc Son N.T. Le et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Additional Contribution of Emerging Risk Factors to the Prediction of the Risk of Type 2 Diabetes: Evidence From the Western New York Study
- (2008) Saverio Stranges et al. Obesity
- Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes
- (2008) David Sahli et al. THROMBOSIS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started